Inhibition of human steroid 5beta-reductase (AKR1D1) by finasteride and structure of the enzyme-inhibitor complex
about
Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stressMolecular diagnosis of 5α-reductase type II deficiency in Brazilian siblings with 46,XY disorder of sex developmentCharacterization of disease-related 5beta-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency.New frontiers in androgen biosynthesis and metabolism.Rate of steroid double-bond reduction catalysed by the human steroid 5β-reductase (AKR1D1) is sensitive to steroid structure: implications for steroid metabolism and bile acid synthesisSubstrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1)Activities of aldo-keto reductase 1 enzymes on two inhaled corticosteroids: implications for the pharmacological effects of inhaled corticosteroidsIn-Depth Dissection of the P133R Mutation in Steroid 5β-Reductase (AKR1D1): A Molecular Basis of Bile Acid DeficiencyEffects of mitotane treatment on human steroid metabolism: implications for patient management.5β-Reduced steroids and human Δ(4)-3-ketosteroid 5β-reductase (AKR1D1).Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer.Carbon-carbon double-bond reductases in nature.Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure.Ten years of intraoperative floppy iris syndrome in the era of α-blockers.
P2860
Q30371274-734D52C6-254C-4AF8-A4B9-0E06C09AF3EAQ30412142-0782FEE3-6AB5-45FF-8273-E59FAB5FEF64Q34042571-53D6CEB5-8D63-4A9B-A4D5-08681E352A3EQ34100727-4489C565-4C87-489B-A7D6-5DE6FD74B1B8Q34179770-6BF710CF-3059-4307-BA21-4A109EFFB8A2Q34669224-C0D8DDC6-5B40-45DF-8104-9A30D0A12E9AQ35000370-8C6E0C9A-4144-4B94-AA88-7833C9263671Q36418305-4F7E35BC-F7B0-453C-8C78-0A27B48BC4EFQ36928036-4956E57F-EFAD-410D-9F0A-BF98F3B1178FQ37677101-AED6CDFF-9ABD-4CA8-AF16-F141E292F9BDQ37818297-1EFF6C2A-C83F-4143-AF56-399BE719A0F6Q38205904-A46B9F2F-1787-494C-9D40-643BFB0BF2DCQ38845916-1CD72D01-E3E5-4392-A44D-CE7329A8FA85Q42198644-6DEAF0BE-BD8F-441C-9E7F-74AEBCC26C9FQ55364267-77BE10FC-B776-49F1-88A4-5603C98F4BB4
P2860
Inhibition of human steroid 5beta-reductase (AKR1D1) by finasteride and structure of the enzyme-inhibitor complex
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inhibition of human steroid 5b ...... f the enzyme-inhibitor complex
@ast
Inhibition of human steroid 5b ...... f the enzyme-inhibitor complex
@en
Inhibition of human steroid 5b ...... f the enzyme-inhibitor complex
@nl
type
label
Inhibition of human steroid 5b ...... f the enzyme-inhibitor complex
@ast
Inhibition of human steroid 5b ...... f the enzyme-inhibitor complex
@en
Inhibition of human steroid 5b ...... f the enzyme-inhibitor complex
@nl
altLabel
Inhibition of Human Steroid 5 ...... f the Enzyme-Inhibitor Complex
@en
prefLabel
Inhibition of human steroid 5b ...... f the enzyme-inhibitor complex
@ast
Inhibition of human steroid 5b ...... f the enzyme-inhibitor complex
@en
Inhibition of human steroid 5b ...... f the enzyme-inhibitor complex
@nl
P2860
P356
P1476
Inhibition of human steroid 5b ...... f the enzyme-inhibitor complex
@en
P2093
David W Christianson
Jason E Drury
P2860
P304
19786-19790
P356
10.1074/JBC.C109.016931
P407
P577
2009-06-10T00:00:00Z